Back to Search
EUNSUNG KIM, M.D.
M.D.
Sports Medicine (Family Medicine) Physician
NPI: 1306371695IndividualAccepts Medicare
Specialties, Licenses & Credentials
Sports Medicine (Family Medicine) PhysicianPrimary
Family Medicine — Sports Medicine
Code: 207QS0010X
R9792(TX)
CMS Specialties
PrimaryFAMILY PRACTICE
Education
OTHER
Class of 2017
Research & Publications (20)
Revisiting stage IIIB and IV non-small cell lung cancer: analysis of the surveillance, epidemiology, and end results data.
PMID 19318668·Chest·2009
8-other
A phase 2 study of cetuximab in combination with docetaxel in chemotherapy-refractory/resistant patients with advanced nonsmall cell lung cancer.
PMID 19208430·Cancer·2009
3-trial
Canonical transient receptor potential channel (TRPC)3 and TRPC6 associate with large-conductance Ca2+-activated K+ (BKCa) channels: role in BKCa trafficking to the surface of cultured podocytes.
PMID 19052171·Mol Pharmacol·2009
4-observational
Gefitinib versus docetaxel in previously treated non-small-cell lung cancer (INTEREST): a randomised phase III trial.
PMID 19027483·Lancet·2008
3-trial
Nephrin binds to the COOH terminus of a large-conductance Ca2+-activated K+ channel isoform and regulates its expression on the cell surface.
PMID 18480178·Am J Physiol Renal Physiol·2008
7-preclinical
The importance of accurate lymph node staging in early and locally advanced non-small cell lung cancer: an update on available techniques.
PMID 17589301·J Thorac Oncol·2007
6-review
Interactions with filamin A stimulate surface expression of large-conductance Ca2+-activated K+ channels in the absence of direct actin binding.
PMID 17586600·Mol Pharmacol·2007
8-other
Alternatively spliced C-terminal domains regulate the surface expression of large conductance calcium-activated potassium channels.
PMID 17478049·Neuroscience·2007
7-preclinical
Beta1-subunits increase surface expression of a large-conductance Ca2+-activated K+ channel isoform.
PMID 17329633·J Neurophysiol·2007
8-other
Novel combinations with docetaxel in the treatment of non-small-cell lung cancer.
PMID 16384541·Clin Lung Cancer·2005
6-review
Phase II study of the farnesyltransferase inhibitor lonafarnib with paclitaxel in patients with taxane-refractory/resistant nonsmall cell lung carcinoma.
PMID 16028213·Cancer·2005
3-trial
Cetuximab as a single agent or in combination with chemotherapy in lung cancer.
PMID 15638964·Clin Lung Cancer·2004
6-review
Phase II study of a multidisciplinary approach with induction chemotherapy, followed by surgical resection, radiation therapy, and consolidation chemotherapy for unresectable malignant thymomas: final report.
PMID 15140551·Lung Cancer·2004
3-trial
Treatment of metastatic head and neck cancer: chemotherapy and novel agents.
PMID 12619547·Cancer Treat Res·2003
6-review
Docetaxel and radiation as combined-modality therapy.
PMID 12108904·Oncology (Williston Park)·2002
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 9090 KATY FWY STE 200
HOUSTON, TX 77024 - Phone
- (832) 522-8720
Quick Facts
- NPI
- 1306371695
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 9
- Publications
- 20
Are you this provider?
Claim Your Profile